|良性前列腺疾病诊疗进展专家研讨会等你来!-MedSci.cn - 风湿免疫
Baidu
map

直播预告|良性前列腺疾病诊疗进展专家研讨会等你来!

2020-05-04 梅斯 MedSci原创

新冠病毒全球肆虐,虽然目前我国新冠病毒肺炎疫情已经基本得到控制,但面对境外输入病例,防控形式依然严峻,人群的有效防护依然不可松懈,慢病诊疗面临患者救治和预防感染的双重压力,如何在疫情防控期间规范诊疗,

新冠病毒全球肆虐,虽然目前我国新冠病毒肺炎疫情已经基本得到控制,但面对境外输入病例,防控形式依然严峻,人群的有效防护依然不可松懈,慢病诊疗面临患者救治和预防感染的双重压力,如何在疫情防控期间规范诊疗,同时做好患者管理是当前工作的重点。

 

前列腺疾病是男性常见病、多发病,一旦患上该病,往往有尿频、尿急、尿痛、排尿无力、滴沥不尽等症状,严重影响男性的身体健康和生活质量。现代医学对前列腺疾病的诊疗水平仍有待提高,近年来,中西医结合治疗效果突出,夏茘芪胶囊“快治慢养”的治疗理念为临床治疗带来了新思路,为患者带来了新希望。

 

为提升良性前列腺疾病诊疗水平,由中华中医药学会络病分会主办,以岭药业支持的“泌尿男科暨良性前列腺疾病诊疗专家论坛”将于5月7日19:00-20:30举办,特邀中国医师协会泌尿外科分会执行总干事、国家癌症中心中国医学科学院肿瘤医院邢念增教授担任大会主席,中、西医各科专家在线研讨,解读前列腺增生、慢性前列腺炎诊疗进展及临床应用。

“泌尿男科暨良性前列腺疾病诊疗专家论坛”将于5月7日19:00-20:30举办

 

扫描或长按海报识别二维码即可收看!欢迎围观!

 

直播时间:2020年 5月7日 19:00-20:30

 

希望本次研讨会能够为广大临床医师带来良性前列腺疾病药物治疗进展的收获与诊疗策略的启发。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2037715, encodeId=2bbd203e715da, content=<a href='/topic/show?id=30a03252461' target=_blank style='color:#2F92EE;'>#前列腺疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32524, encryptionId=30a03252461, topicName=前列腺疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3fb2500073, createdName=124987cdm26暂无昵称, createdTime=Tue Apr 13 19:11:16 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009816, encodeId=3eda20098166f, content=<a href='/topic/show?id=eab38665537' target=_blank style='color:#2F92EE;'>#良性前列腺疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86655, encryptionId=eab38665537, topicName=良性前列腺疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sat May 23 00:11:16 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994839, encodeId=50ee1994839d0, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Mon Jun 08 19:11:16 CST 2020, time=2020-06-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2037715, encodeId=2bbd203e715da, content=<a href='/topic/show?id=30a03252461' target=_blank style='color:#2F92EE;'>#前列腺疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32524, encryptionId=30a03252461, topicName=前列腺疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3fb2500073, createdName=124987cdm26暂无昵称, createdTime=Tue Apr 13 19:11:16 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009816, encodeId=3eda20098166f, content=<a href='/topic/show?id=eab38665537' target=_blank style='color:#2F92EE;'>#良性前列腺疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86655, encryptionId=eab38665537, topicName=良性前列腺疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sat May 23 00:11:16 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994839, encodeId=50ee1994839d0, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Mon Jun 08 19:11:16 CST 2020, time=2020-06-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2037715, encodeId=2bbd203e715da, content=<a href='/topic/show?id=30a03252461' target=_blank style='color:#2F92EE;'>#前列腺疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32524, encryptionId=30a03252461, topicName=前列腺疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3fb2500073, createdName=124987cdm26暂无昵称, createdTime=Tue Apr 13 19:11:16 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2009816, encodeId=3eda20098166f, content=<a href='/topic/show?id=eab38665537' target=_blank style='color:#2F92EE;'>#良性前列腺疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86655, encryptionId=eab38665537, topicName=良性前列腺疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sat May 23 00:11:16 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994839, encodeId=50ee1994839d0, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Mon Jun 08 19:11:16 CST 2020, time=2020-06-08, status=1, ipAttribution=)]
    2020-06-08 kcb069
Baidu
map
Baidu
map
Baidu
map